TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30372761

Group type: EXPERIMENTAL
Intervention: Adaptive stimulus selection algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random stimulus selection
Number of subjects: 0
Study: 27587557

Group type: EXPERIMENTAL
Intervention: mHealth intervention (smartphone application for patients and monitoring website for physiotherapists)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 157
Study: 24760382

Group type: COMPARATOR
Intervention: Micronutrients supplementation for 6 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Probiotics supplementation for 3 months
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (no supplements)
Number of subjects: 127
Study: 23216674

Group type: EXPERIMENTAL
Intervention: IFNβ‐1a, 44 μg subcutaneously three times weekly (tiw)
Number of subjects: 129

Group type: COMPARATOR
Intervention: IFNβ‐1b, 250 μg subcutaneously every other day
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 129
Study: 19591987

Group type: EXPERIMENTAL
Intervention: Follicular fluid with higher estradiol concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follicular fluid with higher testosterone concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follicular fluid with higher progesterone concentrations
Number of subjects: 0
Study: 18070305

Group type: EXPERIMENTAL
Intervention: Tilt training (daily sessions for three months)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tilt training
Number of subjects: 46
Study: 16250265

Group type: EXPERIMENTAL
Intervention: Fluvastatin therapy for 12 weeks
Number of subjects: 0
Study: 12020980

Group type: EXPERIMENTAL
Intervention: Lipid-lowering fibrate (gemfibrozil 600 mg orally twice daily for 3 months, then combined with HRT for 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (2 mg oestradiol + 1 mg norethisterone acetate once daily for 3 months, then combined with gemfibrozil for 6 months)
Number of subjects: 0
Study: 10541127

Group type: EXPERIMENTAL
Intervention: Valved PICC
Number of subjects: 362

Group type: COMPARATOR
Intervention: Clamped PICC
Number of subjects: 362
Study: 8998395

Group type: EXPERIMENTAL
Intervention: Mirtazapine 20 mg/day (titrated up to 60 mg/day)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Doxepin 75 mg/day (titrated up to 300 mg/day)
Number of subjects: 163
Study: 2223891

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program
Number of subjects: 50

Group type: COMPARATOR
Intervention: No-contact control condition
Number of subjects: 50
Study: 31451252

Group type: EXPERIMENTAL
Intervention: Nutrition Intervention (NI) - EPA-enriched nutrition supplement (2 bottles/day, 550 kcal/day) during NACRT
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal Diet (ND)
Number of subjects: 62
Study: 30379936

Group type: COMPARATOR
Intervention: Standard dose pioglitazone (15 mg/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Low dose pioglitazone (7.5 mg/day)
Number of subjects: 75
Study: 26874974

Group type: EXPERIMENTAL
Intervention: Progression-free survival (PFS)/time to progression (TTP)
Number of subjects: 8617

Group type: EXPERIMENTAL
Intervention: Objective response rate (ORR)
Number of subjects: 8617

Group type: EXPERIMENTAL
Intervention: Hazard ratios (HRs) of PFS/TTP
Number of subjects: 8617

Group type: EXPERIMENTAL
Intervention: PFS/OS correlation for HER2-positive MBC patients
Number of subjects: 8617
Study: 24182347

Group type: EXPERIMENTAL
Intervention: sPD-1 concentrations in early RA (median 0.421 ng/mL, IQR 0.04-2.560 ng/mL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Change in sPD-1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: sPD-1 concentration
Number of subjects: 34
Study: 22373720

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 4463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4463
Study: 20560112

Group type: EXPERIMENTAL
Intervention: Immulina® (400 mg/day) for seven days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Immulina® (200 mg/day) for seven days
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Immulina® (200 mg and 400 mg per day) for seven days
Number of subjects: 21
Study: 18572352

Group type: EXPERIMENTAL
Intervention: Medtronic Vascular Talent Thoracic Stent Graft System
Number of subjects: 195

Group type: COMPARATOR
Intervention: Open surgery (retrospective control)
Number of subjects: 195
Study: 15653019

Group type: EXPERIMENTAL
Intervention: Early interventional strategy (IS)
Number of subjects: 1810

Group type: COMPARATOR
Intervention: Conservative strategy (CS)
Number of subjects: 1810
Study: 12451305

Group type: EXPERIMENTAL
Intervention: Standing on two legs with the eyes open
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standing on two legs with the eyes closed
Number of subjects: 100
Study: 10470387

Group type: EXPERIMENTAL
Intervention: Group P50: propofol 1% 10 ml/thiopentone 2.5% 10 ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group P75: propofol 1% 15 ml/thiopentone 2.5% 5 ml
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group P100: propofol 1% 20 ml/lignocaine 1% 4 ml
Number of subjects: 90

Group type: COMPARATOR
Intervention: Thiopentone 2.5% (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol/thiopentone admixture
Number of subjects: 90
Study: 9156906

Group type: EXPERIMENTAL
Intervention: Dexamethasone (optimal dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doppler color ultrasonography
Number of subjects: 0
Study: 1862227

Group type: EXPERIMENTAL
Intervention: Combined regimen of intramniotic prostaglandin (PG) F2a injection and intracervical laminaria tents (group A, 50 women)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Intramniotic PGF2a injection only (group B, 51 women)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Laminaria tents followed by intracervical PGF2a tablets insertion (group C, 27 women)
Number of subjects: 128
Study: 7091604

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intramuscular papaveretum
Number of subjects: 100
Study: 31982477

Group type: EXPERIMENTAL
Intervention: 100% Vitamin C claim
Number of subjects: 3815

Group type: EXPERIMENTAL
Intervention: Health warning
Number of subjects: 3815

Group type: EXPERIMENTAL
Intervention: Fruit image
Number of subjects: 3815

Group type: EXPERIMENTAL
Intervention: 100% Vitamin C claim without health warning
Number of subjects: 3815
Study: 31274187

Group type: EXPERIMENTAL
Intervention: Posterior retroperitoneal approach (PRA)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Lateral transperitoneal approach (LTA)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Aldosterone-producing adenoma (PRA)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Both PRA and LTA
Number of subjects: 77
Study: 30169201

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise (3 times per week for 6 months, 72 sessions total, intensity from 50% to 70% of one repetition maximum)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham training (negligible non‐progressed intensity)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 60
Study: 25756064

Group type: EXPERIMENTAL
Intervention: Functional fitness and cognitive training for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: No training program (Control)
Number of subjects: 34
Study: 25432118

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (group LP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open surgery (group OP)
Number of subjects: 60
Study: 21859051

Group type: EXPERIMENTAL
Intervention: 3 mg melatonin nightly for 30 days
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo nightly for 30 days
Number of subjects: 61
Study: 19008077

Group type: EXPERIMENTAL
Intervention: Valacyclovir 1 g twice daily (n=24)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo (n=23)
Number of subjects: 47
Study: 17879994

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minor components of olive oil
Number of subjects: 0
Study: 15377131

Group type: EXPERIMENTAL
Intervention: Amiodarone (group Ia)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo (group Ib)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Ventricular rate control (diltiazem, group II)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Overall comparison of group I vs group II
Number of subjects: 144
Study: 11248761

Group type: EXPERIMENTAL
Intervention: Amlodipine (5mg/daily)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (30mg/daily)
Number of subjects: 58
Study: 9492126

Group type: EXPERIMENTAL
Intervention: 2-octylcyanoacrylate
Number of subjects: 124

Group type: COMPARATOR
Intervention: Standard wound closure techniques
Number of subjects: 124
Study: 8046180

Group type: EXPERIMENTAL
Intervention: Training workshop plus foodservice manual
Number of subjects: 46

Group type: COMPARATOR
Intervention: Manual only
Number of subjects: 46

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 46
Study: 2606287

Group type: EXPERIMENTAL
Intervention: Synonyms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Paraphrases
Number of subjects: 3

Group type: COMPARATOR
Intervention: Repetitions
Number of subjects: 3
Study: 30206690

Group type: EXPERIMENTAL
Intervention: Remifentanil (0.5 µg/kg/min)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 142
Study: 26795935

Group type: EXPERIMENTAL
Intervention: KiVa program (intervention)
Number of subjects: 7010

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 7010
Study: 25601592

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 150
Study: 23418465

Group type: EXPERIMENTAL
Intervention: 2 doses of ADVAX (DNA vaccine) + 2 doses of TBC-M4 (recombinant MVA) in Group A
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 3 doses of TBC-M4 (recombinant MVA) in Group B
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo in both groups
Number of subjects: 32
Study: 20173188

Group type: EXPERIMENTAL
Intervention: Manipulated distribution of locations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulated background texture
Number of subjects: 0
Study: 18164280

Group type: EXPERIMENTAL
Intervention: Learning condition (study of 160 word pairs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (non-learning perceptual priming task)
Number of subjects: 0
Study: 16083539

Group type: EXPERIMENTAL
Intervention: Econopred Plus 1% (EPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pred Fortedagger 1% (PF)
Number of subjects: 0
Study: 12117879

Group type: EXPERIMENTAL
Intervention: Folate supplementation (2 mg folic acid per day for three months)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 11
Study: 10513037

Group type: EXPERIMENTAL
Intervention: Instruction/supervision/reinforcement/stimulation for six months
Number of subjects: 296

Group type: COMPARATOR
Intervention: Instruction/supervision only
Number of subjects: 296
Study: 7750598

Group type: EXPERIMENTAL
Intervention: Intrauterine insemination (IUI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Natural intercourse
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 30
Study: 1983112

Group type: COMPARATOR
Intervention: nizatidine (300 mg h.s.)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: famotidine (40 mg h.s.)
Number of subjects: 20
Study: 7016432

Group type: EXPERIMENTAL
Intervention: 1.0 mg of 15-methyl-PGF2 alpha methyl ester in a vaginal suppository
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 1001
Study: 31117815

Group type: EXPERIMENTAL
Intervention: REACH-HF intervention (home-based, health-professional-facilitated, self-management programme) over 12 weeks
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 97
Study: 27866454

Group type: EXPERIMENTAL
Intervention: Pemetrexed continuation maintenance therapy
Number of subjects: 87
Study: 25412116

Group type: EXPERIMENTAL
Intervention: α1-antitrypsin deficiency (AATD)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: usual COPD
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: AATD and usual COPD
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 10
Study: 24140442

Group type: EXPERIMENTAL
Intervention: Prolonged release oxycodone-naloxone (5.0 mg oxycodone, 2.5 mg naloxone, twice per day, up-titrated to a maximum of 40 mg oxycodone, 20 mg naloxone, twice per day)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Prolonged release oxycodone-naloxone (during open-label extension phase)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Prolonged release oxycodone-naloxone
Number of subjects: 276
Study: 21873926

Group type: EXPERIMENTAL
Intervention: Corneal refractive therapy
Number of subjects: 30
Study: 19188184

Group type: EXPERIMENTAL
Intervention: p53 synthetic long peptide (p53-SLP) vaccine, administered twice
Number of subjects: 10
Study: 17595592

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT) with estradiol patches (50 microg/24 h) and oral medroxyprogesterone acetate (2.5 mg/d)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15188978

Group type: EXPERIMENTAL
Intervention: NIDCAP
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control
Number of subjects: 26
Study: 11932073

Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 40
Study: 9672273

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg per day for 5 years
Number of subjects: 5408

Group type: COMPARATOR
Intervention: Placebo for 5 years
Number of subjects: 5408

Group type: EXPERIMENTAL
Intervention: Tamoxifen among women using hormone-replacement therapy
Number of subjects: 5408

Group type: COMPARATOR
Intervention: Placebo among women using hormone-replacement therapy
Number of subjects: 5408

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 5408

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5408
Study: 8023775

Group type: EXPERIMENTAL
Intervention: L-propionylcarnitine (15 mg/kg)
Number of subjects: 31
Study: 3076382

Group type: EXPERIMENTAL
Intervention: Total lymphoid irradiation (TLI) (radiation dose, 20-30 Gy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cyclosporin A (CsA)
Number of subjects: 20
Study: 29031641

Group type: EXPERIMENTAL
Intervention: Standardised AT conditioning protocol (10×25s plantarflexion contractions at 50% MVIC)
Number of subjects: 10
Study: 25675393

Group type: EXPERIMENTAL
Intervention: Bedaquiline
Number of subjects: 10
Study: 23003916

Group type: EXPERIMENTAL
Intervention: Modified perforated bovine collagen membranes (MPM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Occlusive bovine collagen membranes (OM)
Number of subjects: 20
Study: 21300712

Group type: EXPERIMENTAL
Intervention: Cardiovascular Health Awareness Program (CHAP)
Number of subjects: 15
Study: 19271065

Group type: EXPERIMENTAL
Intervention: Propofol infusion (Group P)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desflurane inhalation (Group D)
Number of subjects: 30
Study: 16548950

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube-Suction Airway (LTS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: ProSeal Laryngeal Mask Airway (PLMA)
Number of subjects: 36
Study: 12765890

Group type: EXPERIMENTAL
Intervention: parecoxib 40 mg i.v.
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo (normal saline)
Number of subjects: 48
Study: 10867454

Group type: EXPERIMENTAL
Intervention: Simple closure with postsurgery medical treatment (proton pump inhibitors for 1 month)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Vagotomy and pyloroplasty with no additional medical treatment
Number of subjects: 207
Study: 9089001

Group type: EXPERIMENTAL
Intervention: Demotussol Hustensirup (syrup)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sinecod Sirup (syrup)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Demotussol Tabletten (tablet)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Demotussol Hustentropfen (solution)
Number of subjects: 18
Study: 8404115

Group type: EXPERIMENTAL
Intervention: Smoking intervention with daily use of a metered-dose inhaler with ipratropium bromide
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Smoking intervention with inhalation of placebo
Number of subjects: 5887

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 5887
Study: 2957569

Group type: EXPERIMENTAL
Intervention: Org OD 14 (2 micrograms/day/rat for 14 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Org OD 14 (10 micrograms/day/rat for 14 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oestradiol benzoate (10 micrograms/day/rat for 14 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Org OD 14 (2.5 mg/day for 6 months)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29724172

Group type: EXPERIMENTAL
Intervention: Paramedic-delivered Care Transitions Intervention (CTI) consisting of one home visit and up to three follow-up phone calls.
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Control group (standard care without the CTI).
Number of subjects: 2400
Study: 28306636

Group type: EXPERIMENTAL
Intervention: perindopril/indapamide/amlodipine 5/1.25/5 mg
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: perindopril/indapamide/amlodipine 10/2.5/10 mg (up-titration)
Number of subjects: 454

Group type: COMPARATOR
Intervention: perindopril/indapamide 5/1.25 mg
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: ABPM
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: HBPM
Number of subjects: 454
Study: 25675176

Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide use
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Adenoma Detection Rate (ADR)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: ADR in lower two quartiles
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: ADR in upper middle quartile
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: ADR in upper quartile
Number of subjects: 118
Study: 23059198

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) present
Number of subjects: 4133

Group type: COMPARATOR
Intervention: No Diabetes Mellitus (DM)
Number of subjects: 4133

Group type: EXPERIMENTAL
Intervention: Diabetic control strategy
Number of subjects: 4133
Study: 19779804

Group type: EXPERIMENTAL
Intervention: DASI trained physicians (n = 32)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group physicians (n = 30)
Number of subjects: 62
Study: 18220456

Group type: EXPERIMENTAL
Intervention: School nursing service
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no school nursing service)
Number of subjects: 104
Study: 21504973

Group type: EXPERIMENTAL
Intervention: Muscadine grape seed supplementation (1300 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15888038

Group type: EXPERIMENTAL
Intervention: Steroid avoidance regimen (no steroids at all)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Steroid withdrawal regimen (steroids for the first 3 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 50
Study: 12218418

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9758395

Group type: EXPERIMENTAL
Intervention: Fuji Bond LC (FB)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Bisco One‐step (BC)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Scotchbond Multi‐purpose (SB)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Prime & Bond 2.0 (PB)
Number of subjects: 96
Study: 7851224

Group type: EXPERIMENTAL
Intervention: 6-week self-management education program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 24
Study: 3134629

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 60
Study: 31987528

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups (A, B, C)
Number of subjects: 30
Study: 30284018

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study: 27214389

Group type: EXPERIMENTAL
Intervention: Glatiramer acetate treatment
Number of subjects: 64
Study: 27020837

Group type: EXPERIMENTAL
Intervention: Fentanyl sublingual spray (FSS) effective dose (100-1600 µg)
Number of subjects: 50
Study: 24615047

Group type: EXPERIMENTAL
Intervention: CYP2C9*3 variant genotypes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Wild type genotype
Number of subjects: 24
Study: 23035730

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream
Number of subjects: 183

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 183
Study: 19650674

Group type: EXPERIMENTAL
Intervention: BDP/F 400 microg/24 microg (four inhalations of Foster BDP/F 100 microg/6 microg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: BDP CFC 1000 microg (four inhalations of Becotide Forte 250 microg) plus formoterol 24 microg (four inhalations of Atimos 6 microg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17381944

Group type: EXPERIMENTAL
Intervention: Free F&V distribution programme
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: Multicomponent programme (classroom curriculum and parental involvement)
Number of subjects: 939

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 939
Study: 15479896

Group type: EXPERIMENTAL
Intervention: 30 mg oral prednisolone/day for three weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50